103 related articles for article (PubMed ID: 38721737)
1. Management of hyperleukocytosis in pediatric acute myeloid leukemia using immediate chemotherapy without leukapheresis: results from the NOPHO-DBH AML 2012 Protocol.
Zeller B; Arad-Cohen N; Cheuk D; De Moerloose B; Navarro JMF; Hasle H; Jahnukainen K; Juul-Dam KL; Kaspers G; Kovalova Z; Jonsson OG; Lausen B; Munthe-Kaas M; Nystrom UN; Palle J; Pasauliene R; Pronk CJ; Saks K; Tierens A; Abrahamsson J
Haematologica; 2024 May; ():. PubMed ID: 38721737
[TBL] [Abstract][Full Text] [Related]
2. Minimally early morbidity in children with acute myeloid leukemia and hyperleukocytosis treated with prompt chemotherapy without leukapheresis.
Chen KH; Liu HC; Liang DC; Hou JY; Huang TH; Chang CY; Yeh TC
J Formos Med Assoc; 2014 Nov; 113(11):833-8. PubMed ID: 24534017
[TBL] [Abstract][Full Text] [Related]
3. Leukapheresis in acute myeloid leukemia patients with hyperleukocytosis: A single center experience.
Berber I; Kuku I; Erkurt MA; Kaya E; Bag HG; Nizam I; Koroglu M; Ozgul M; Bazna S
Transfus Apher Sci; 2015 Oct; 53(2):185-90. PubMed ID: 25843763
[TBL] [Abstract][Full Text] [Related]
4. Hyperleukocytosis predicts inferior clinical outcome in pediatric acute myeloid leukemia.
Xu LH; Wang JW; Wang Y; Yang FY
Hematology; 2020 Dec; 25(1):507-514. PubMed ID: 33317436
[TBL] [Abstract][Full Text] [Related]
5. Early Complications of Hyperleukocytosis and Leukapheresis in Childhood Acute Leukemias.
Abla O; Angelini P; Di Giuseppe G; Kanani MF; Lau W; Hitzler J; Sung L; Naqvi A
J Pediatr Hematol Oncol; 2016 Mar; 38(2):111-7. PubMed ID: 26794706
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics and outcomes of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis managed with different cytoreductive methods.
Christakopoulos GE; Walker KN; Smith J; Takemoto CM; Zheng Y; Pui CH; Ribeiro RC; Wang L; Pounds SB; Rubnitz JE; Inaba H
Cancer; 2023 Jun; 129(12):1873-1884. PubMed ID: 36943896
[TBL] [Abstract][Full Text] [Related]
7. Pediatric acute myeloid leukemia and hyperleukocytosis with WBC count greater than 50 × 10
Zhang A; Liu L; Zong S; Chang L; Chen X; Yang W; Guo Y; Zhang L; Zou Y; Chen Y; Zhang Y; Ruan M; Zhu X
Int J Hematol; 2023 Dec; 118(6):737-744. PubMed ID: 37733171
[TBL] [Abstract][Full Text] [Related]
8. [Successful induction therapy for acute myeloid leukemia complicated with brain hemorrhage and hyperleukocytosis].
Miyazaki T; Abe N; Yamazaki E; Koyama S; Miyashita K; Takahashi H; Nakajima Y; Tachibana T; Kamijo A; Tomita N; Ishigastubo Y
Rinsho Ketsueki; 2016 Feb; 57(2):180-5. PubMed ID: 26935637
[TBL] [Abstract][Full Text] [Related]
9. Leukapheresis and exchange transfusion in children with acute leukemia and hyperleukocytosis. A single center experience.
Haase R; Merkel N; Diwan O; Elsner K; Kramm CM
Klin Padiatr; 2009; 221(6):374-8. PubMed ID: 19890790
[TBL] [Abstract][Full Text] [Related]
10. Leukapheresis do not improve early death rates in acute myeloid leukemia patients with hyperleukocytosis.
Malkan UY; Ozcebe OI
Transfus Apher Sci; 2017 Dec; 56(6):880-882. PubMed ID: 29153308
[TBL] [Abstract][Full Text] [Related]
11. Impact of pre-induction therapy leukapheresis on treatment outcome in adult acute myelogenous leukemia presenting with hyperleukocytosis.
Thiébaut A; Thomas X; Belhabri A; Anglaret B; Archimbaud E
Ann Hematol; 2000 Sep; 79(9):501-6. PubMed ID: 11043421
[TBL] [Abstract][Full Text] [Related]
12. Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis.
Bug G; Anargyrou K; Tonn T; Bialleck H; Seifried E; Hoelzer D; Ottmann OG
Transfusion; 2007 Oct; 47(10):1843-50. PubMed ID: 17880610
[TBL] [Abstract][Full Text] [Related]
13. Leukapheresis reduces 4-week mortality in acute myeloid leukemia patients with hyperleukocytosis - a retrospective study from a tertiary center.
Nan X; Qin Q; Gentille C; Ensor J; Leveque C; Pingali SR; Phan AT; Rice L; Iyer S
Leuk Lymphoma; 2017 Sep; 58(9):1-11. PubMed ID: 28140714
[TBL] [Abstract][Full Text] [Related]
14. Leukapheresis and low-dose chemotherapy do not reduce early mortality in acute myeloid leukemia hyperleukocytosis: a systematic review and meta-analysis.
Oberoi S; Lehrnbecher T; Phillips B; Hitzler J; Ethier MC; Beyene J; Sung L
Leuk Res; 2014 Apr; 38(4):460-8. PubMed ID: 24472688
[TBL] [Abstract][Full Text] [Related]
15. Leukapheresis Does Not Improve Early Survival Outcome of Acute Myeloid Leukemia with Leukostasis Patients - A Dual-Center Retrospective Cohort Study.
Rinaldi I; Sari RM; Tedhy VU; Winston K
J Blood Med; 2021; 12():623-633. PubMed ID: 34290537
[TBL] [Abstract][Full Text] [Related]
16. The effect of therapeutic leukapheresis on early complications and outcomes in patients with acute leukemia and hyperleukocytosis: a propensity score-matched study.
Choi MH; Choe YH; Park Y; Nah H; Kim S; Jeong SH; Kim HO
Transfusion; 2018 Jan; 58(1):208-216. PubMed ID: 28960357
[TBL] [Abstract][Full Text] [Related]
17. Leukapheresis in patients newly diagnosed with acute myeloid leukemia.
Villgran V; Agha M; Raptis A; Hou JZ; Farah R; Lim SH; Redner RL; Im A; Sehgal A; Dorritie KA; Kiss JE; Normolle D; Boyiadzis M
Transfus Apher Sci; 2016 Oct; 55(2):216-220. PubMed ID: 27470709
[TBL] [Abstract][Full Text] [Related]
18. Management of Hyperleukocytosis in Childhood Acute Leukemia Without Leukapheresis and Rasburicase Prophylaxis.
Aylan Gelen S; Sarper N; Zengin E; Azizoğlu M
J Pediatr Hematol Oncol; 2022 Jan; 44(1):12-18. PubMed ID: 34054042
[TBL] [Abstract][Full Text] [Related]
19. Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study.
Stahl M; Shallis RM; Wei W; Montesinos P; Lengline E; Neukirchen J; Bhatt VR; Sekeres MA; Fathi AT; Konig H; Luger S; Khan I; Roboz GJ; Cluzeau T; Martínez-Cuadron D; Raffoux E; Germing U; Umakanthan JM; Mukherjee S; Brunner AM; Miller A; McMahon CM; Ritchie EK; Rodríguez-Veiga R; Itzykson R; Boluda B; Rabian F; Tormo M; Acuña-Cruz E; Rabinovich E; Yoo B; Cano I; Podoltsev NA; Bewersdorf JP; Gore S; Zeidan AM
Leukemia; 2020 Dec; 34(12):3149-3160. PubMed ID: 32132655
[TBL] [Abstract][Full Text] [Related]
20. Comparing leukapheresis protocols for an AML patient with symptomatic leukostasis.
Cline A; Jajosky R; Shikle J; Bollag R
J Clin Apher; 2018 Jun; 33(3):396-400. PubMed ID: 28940295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
